ArticleHeliyon2025

Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report.

Anita Borsati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.